---
title: "Deep molecular phenotyping in the EPIC-Potsdam study provides insights into cardiometabolic disease etiology"
author: 
    - name: "Matthias B Schulze"
      affiliations: 
        - name: "German Institute of Human Nutrition"
date: "2022-09-12"
---

<iframe src="https://app.box.com/embed/s/al1dsi050tdtrwl5v7hz1z4wmfw03rsa?sortColumn=date&view=list" width="800" height="550" frameborder="0" allowfullscreen webkitallowfullscreen msallowfullscreen></iframe>

![](/images/speakers/matthias-b-schulze.png){style="float: left; padding: 20px; border-radius: 30px; width: 120px"} Dr. Schulze's research focuses on dietary risk factors for type 2 diabetes, dietary pattern analysis, biomarkers of nutritional intake, gene-diet interaction, and biochemical and genetic predictors of diabetes and its complications. Further research interests include risk prediction models and healthy metabolic obesity. Dr. Schulze is the Principal Investigator of the EPIC-Potsdam study and a center Principal Investigator of the NAKO Health Study.
